Answer
Aug 21, 2024 - 03:46 PM
The bioavailability of the inhaler is approximately 30%. This means that about 30% of the drug reaches the systemic circulation, which is important for its effectiveness in treating COPD.
Do you have the same question? Follow this Question
Aug 21, 2024 - 03:46 PM
View all Stiolto Respimat (Tiotropium Bromide / Olodaterol) Questions & Answers